These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28591560)

  • 21. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
    Willier S; Butt E; Grunewald TG
    Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.
    Valdés-Rives SA; González-Arenas A
    Mediators Inflamm; 2017; 2017():9173090. PubMed ID: 29430083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte autotaxin expression promotes liver fibrosis and cancer.
    Kaffe E; Katsifa A; Xylourgidis N; Ninou I; Zannikou M; Harokopos V; Foka P; Dimitriadis A; Evangelou K; Moulas AN; Georgopoulou U; Gorgoulis VG; Dalekos GN; Aidinis V
    Hepatology; 2017 Apr; 65(4):1369-1383. PubMed ID: 27981605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721.
    Zhang R; Zhang Z; Pan X; Huang X; Huang Z; Zhang G
    Anat Rec (Hoboken); 2011 Mar; 294(3):406-11. PubMed ID: 21337710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancer.
    Teo K; Brunton VG
    Biochem J; 2014 Oct; 463(1):157-65. PubMed ID: 25195735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.
    Benbow JH; Thompson KJ; Cope HL; Brandon-Warner E; Culberson CR; Bossi KL; Li T; Russo MW; Gersin KS; McKillop IH; deLemos AS; Schrum LW
    Am J Pathol; 2016 Jan; 186(1):145-58. PubMed ID: 26603137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease.
    Flores-López M; García-Marchena N; Pavon FJ; Lara E; Porras-Perales O; Araos P; Requena-Ocaña N; Torres-Galván S; Mañas-Padilla MC; Rubio G; Suárez J; Santín LJ; Rodríguez de Fonseca F; Castilla-Ortega E; García-Fernández MI; Serrano A
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
    Yopp AC; Choti MA
    Dig Dis; 2015 Sep; 33(5):642-7. PubMed ID: 26398208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.
    Khemlina G; Ikeda S; Kurzrock R
    Mol Cancer; 2017 Aug; 16(1):149. PubMed ID: 28854942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Ye J; Li TS; Xu G; Zhao YM; Zhang NP; Fan J; Wu J
    Cancer Res; 2017 Oct; 77(19):5287-5300. PubMed ID: 28775168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
    Orosa B; García S; Conde C
    Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-B, non-C hepatocellular carcinoma (Review).
    Nishikawa H; Osaki Y
    Int J Oncol; 2013 Nov; 43(5):1333-42. PubMed ID: 23969900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
    Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
    Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
    Panupinthu N; Lee HY; Mills GB
    Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
    Torres DM; Harrison SA
    Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.
    Jain D; Nayak NC; Kumaran V; Saigal S
    Arch Pathol Lab Med; 2013 Jul; 137(7):961-6. PubMed ID: 23808468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.